Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.
Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check42 days agoChange DetectedThe latest update on December 12, 2024, includes detailed results on primary and secondary outcome measures related to treatment emergent adverse events, hemoglobin changes, and various hematology assessments, while previous entries regarding total adverse events and APL-2 pharmacokinetics have been removed.SummaryDifference64%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference3%
- Check63 days agoChange DetectedThe website has added new features while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference5%
- Check78 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.